FC-084-CSA

N/A

Report date: 2024/07/15 20:00:35
NME

Base Information

Drug NameFC-084-CSA
Drug Alias NameFC084CSAFC-084-CSA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAXL receptor tyrosine kinase inhibitors
TargetsAXL receptor tyrosine kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesFindCure Biosciences (ZhongShan) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesFindCure Biosciences (ZhongShan) Co LtdZhongshan Yinuo Weishen New Drug Research and Development Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A